Organization · Venture Capital
Oncology Ventures
Oncology Ventures is a New York-based venture capital firm investing in healthcare data and technology companies focused on improving cancer care. The firm emphasizes innovations in early detection, patient navigation, and data access.
Overview
What Oncology Ventures does
What Oncology Ventures is
Oncology Ventures is a New York-based venture capital firm investing in healthcare data and technology companies focused on improving cancer care. The firm emphasizes innovations in early detection, patient navigation, and data access.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find Oncology Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Oncology Ventures as a funder
Investment thesis
Oncology Ventures focuses on data-driven technologies that transform the cancer care journey from early detection to survivorship, explicitly excluding drug and biotech development.
Focus narrative
Oncology Ventures invests in technologies that tackle various aspects of cancer care, including early detection, patient navigation, data access, and AI-powered treatment optimization. The firm targets healthcare data companies that can address the fragmented and costly nature of the U.S. oncology system, emphasizing innovations that can significantly improve patient outcomes.
Value beyond capital
Oncology Ventures adds value to its portfolio companies by providing access to clinical validation and deal flow through its anchor LP, Texas Oncology, and leveraging the operational experience of its team in the healthcare sector.
Terms and economics
- Typical check
- $1,000,000–$62,000,000
- Sweet spot
- $32,000,000
Focus and fit
- Stages
- Seed · Series A · Series B
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 7
Portfolio context
Notable portfolio companies include: mPATH: Focuses on improving access to lung cancer screenings. Tono: Assists patients in managing side effects and maintaining treatment adherence. Risa: Enhances operational efficiency in cancer centers, resulting in significant cost savings. Lumonus: Aims to reduce administrative errors and costs in radiation oncology. OncoveryCare: Provides mental health support, significantly improving patient depression scores. Concr: Utilizes AI to enhance patient outcomes in cancer treatment. SpotDoc: Aids in early melanoma detection through advanced technology.
Common questions
What to know about Oncology Ventures
Upseed classifies Oncology Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.